Pacific Industries Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: October 10, 2025, 10:57 pm

Competitors of Pacific Industries Ltd

All Competitor Stocks of Pacific Industries Ltd

Quarterly Result

Last Updated: August 20, 2025, 5:20 am

Below is a detailed analysis of the quarterly data for Pacific Industries Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 49.66 Cr.. The value appears to be declining and may need further review. It has decreased from 59.61 Cr. (Mar 2025) to 49.66 Cr., marking a decrease of 9.95 Cr..
• For Expenses, as of Jun 2025, the value is 46.31 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 56.21 Cr. (Mar 2025) to 46.31 Cr., marking a decrease of 9.90 Cr..
• For Operating Profit, as of Jun 2025, the value is 3.35 Cr.. The value appears to be declining and may need further review. It has decreased from 3.40 Cr. (Mar 2025) to 3.35 Cr., marking a decrease of 0.05 Cr..
• For OPM %, as of Jun 2025, the value is 6.75%. The value appears strong and on an upward trend. It has increased from 5.70% (Mar 2025) to 6.75%, marking an increase of 1.05%.
• For Other Income, as of Jun 2025, the value is 1.38 Cr.. The value appears to be declining and may need further review. It has decreased from 2.73 Cr. (Mar 2025) to 1.38 Cr., marking a decrease of 1.35 Cr..
• For Interest, as of Jun 2025, the value is 1.07 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 1.35 Cr. (Mar 2025) to 1.07 Cr., marking a decrease of 0.28 Cr..
• For Depreciation, as of Jun 2025, the value is 2.38 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 2.50 Cr. (Mar 2025) to 2.38 Cr., marking a decrease of 0.12 Cr..
• For Profit before tax, as of Jun 2025, the value is 1.28 Cr.. The value appears to be declining and may need further review. It has decreased from 2.28 Cr. (Mar 2025) to 1.28 Cr., marking a decrease of 1.00 Cr..
• For Tax %, as of Jun 2025, the value is 27.34%. The value appears to be increasing, which may not be favorable. It has increased from -1.75% (Mar 2025) to 27.34%, marking an increase of 29.09%.
• For Net Profit, as of Jun 2025, the value is 0.93 Cr.. The value appears to be declining and may need further review. It has decreased from 2.31 Cr. (Mar 2025) to 0.93 Cr., marking a decrease of 1.38 Cr..
• For EPS in Rs, as of Jun 2025, the value is 1.35. The value appears to be declining and may need further review. It has decreased from 3.35 (Mar 2025) to 1.35, marking a decrease of 2.00.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: August 23, 2025, 2:16 pm

Growth

Last Updated: September 5, 2025, 12:25 pm

Balance Sheet

Last Updated: June 16, 2025, 11:32 am

Below is a detailed analysis of the balance sheet data for Pacific Industries Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 7.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 7.00 Cr..
• For Reserves, as of Mar 2025, the value is 435.00 Cr.. The value appears strong and on an upward trend. It has increased from 427.00 Cr. (Mar 2024) to 435.00 Cr., marking an increase of 8.00 Cr..
• For Borrowings, as of Mar 2025, the value is 73.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 50.00 Cr. (Mar 2024) to 73.00 Cr., marking an increase of 23.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 73.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 70.00 Cr. (Mar 2024) to 73.00 Cr., marking an increase of 3.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 588.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 554.00 Cr. (Mar 2024) to 588.00 Cr., marking an increase of 34.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 106.00 Cr.. The value appears to be declining and may need further review. It has decreased from 115.00 Cr. (Mar 2024) to 106.00 Cr., marking a decrease of 9.00 Cr..
• For CWIP, as of Mar 2025, the value is 1.00 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Mar 2024) to 1.00 Cr., marking an increase of 1.00 Cr..
• For Investments, as of Mar 2025, the value is 203.00 Cr.. The value appears strong and on an upward trend. It has increased from 115.00 Cr. (Mar 2024) to 203.00 Cr., marking an increase of 88.00 Cr..
• For Other Assets, as of Mar 2025, the value is 279.00 Cr.. The value appears to be declining and may need further review. It has decreased from 323.00 Cr. (Mar 2024) to 279.00 Cr., marking a decrease of 44.00 Cr..
• For Total Assets, as of Mar 2025, the value is 588.00 Cr.. The value appears strong and on an upward trend. It has increased from 554.00 Cr. (Mar 2024) to 588.00 Cr., marking an increase of 34.00 Cr..

Notably, the Reserves (435.00 Cr.) exceed the Borrowings (73.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Pacific Industries Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 11.10. This value is within the healthy range. It has decreased from 17.23 (Mar 24) to 11.10, marking a decrease of 6.13.
• For Diluted EPS (Rs.), as of Mar 25, the value is 11.10. This value is within the healthy range. It has decreased from 17.23 (Mar 24) to 11.10, marking a decrease of 6.13.
• For Cash EPS (Rs.), as of Mar 25, the value is 25.68. This value is within the healthy range. It has decreased from 32.87 (Mar 24) to 25.68, marking a decrease of 7.19.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 640.73. It has increased from 629.16 (Mar 24) to 640.73, marking an increase of 11.57.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 640.73. It has increased from 629.16 (Mar 24) to 640.73, marking an increase of 11.57.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 354.65. It has increased from 275.65 (Mar 24) to 354.65, marking an increase of 79.00.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 36.94. This value is within the healthy range. It has decreased from 39.74 (Mar 24) to 36.94, marking a decrease of 2.80.
• For PBIT / Share (Rs.), as of Mar 25, the value is 22.35. This value is within the healthy range. It has decreased from 24.10 (Mar 24) to 22.35, marking a decrease of 1.75.
• For PBT / Share (Rs.), as of Mar 25, the value is 13.96. This value is within the healthy range. It has decreased from 19.32 (Mar 24) to 13.96, marking a decrease of 5.36.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 11.10. This value is within the healthy range. It has decreased from 17.23 (Mar 24) to 11.10, marking a decrease of 6.13.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 11.10. This value is within the healthy range. It has decreased from 17.23 (Mar 24) to 11.10, marking a decrease of 6.13.
• For PBDIT Margin (%), as of Mar 25, the value is 10.41. This value is within the healthy range. It has decreased from 14.41 (Mar 24) to 10.41, marking a decrease of 4.00.
• For PBIT Margin (%), as of Mar 25, the value is 6.30. This value is below the healthy minimum of 10. It has decreased from 8.74 (Mar 24) to 6.30, marking a decrease of 2.44.
• For PBT Margin (%), as of Mar 25, the value is 3.93. This value is below the healthy minimum of 10. It has decreased from 7.00 (Mar 24) to 3.93, marking a decrease of 3.07.
• For Net Profit Margin (%), as of Mar 25, the value is 3.12. This value is below the healthy minimum of 5. It has decreased from 6.25 (Mar 24) to 3.12, marking a decrease of 3.13.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 3.12. This value is below the healthy minimum of 8. It has decreased from 6.25 (Mar 24) to 3.12, marking a decrease of 3.13.
• For Return on Networth / Equity (%), as of Mar 25, the value is 1.73. This value is below the healthy minimum of 15. It has decreased from 2.73 (Mar 24) to 1.73, marking a decrease of 1.00.
• For Return on Capital Employeed (%), as of Mar 25, the value is 3.29. This value is below the healthy minimum of 10. It has decreased from 3.66 (Mar 24) to 3.29, marking a decrease of 0.37.
• For Return On Assets (%), as of Mar 25, the value is 1.30. This value is below the healthy minimum of 5. It has decreased from 2.14 (Mar 24) to 1.30, marking a decrease of 0.84.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.04. This value is below the healthy minimum of 0.2. It has increased from 0.02 (Mar 24) to 0.04, marking an increase of 0.02.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.16. This value is within the healthy range. It has increased from 0.11 (Mar 24) to 0.16, marking an increase of 0.05.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.42. It has increased from 0.35 (Mar 24) to 0.42, marking an increase of 0.07.
• For Current Ratio (X), as of Mar 25, the value is 2.20. This value is within the healthy range. It has increased from 1.98 (Mar 24) to 2.20, marking an increase of 0.22.
• For Quick Ratio (X), as of Mar 25, the value is 1.75. This value is within the healthy range. It has increased from 1.52 (Mar 24) to 1.75, marking an increase of 0.23.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 3.09. This value is below the healthy minimum of 4. It has increased from 1.56 (Mar 24) to 3.09, marking an increase of 1.53.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 4.40. This value is within the healthy range. It has decreased from 8.32 (Mar 24) to 4.40, marking a decrease of 3.92.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 2.32. This value is below the healthy minimum of 3. It has decreased from 4.61 (Mar 24) to 2.32, marking a decrease of 2.29.
• For Enterprise Value (Cr.), as of Mar 25, the value is 177.65. It has increased from 125.36 (Mar 24) to 177.65, marking an increase of 52.29.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.72. This value is below the healthy minimum of 1. It has increased from 0.65 (Mar 24) to 0.72, marking an increase of 0.07.
• For EV / EBITDA (X), as of Mar 25, the value is 6.98. This value is within the healthy range. It has increased from 4.58 (Mar 24) to 6.98, marking an increase of 2.40.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.57. This value is below the healthy minimum of 1. It has decreased from 0.63 (Mar 24) to 0.57, marking a decrease of 0.06.
• For Price / BV (X), as of Mar 25, the value is 0.31. This value is below the healthy minimum of 1. It has increased from 0.28 (Mar 24) to 0.31, marking an increase of 0.03.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.57. This value is below the healthy minimum of 1. It has decreased from 0.63 (Mar 24) to 0.57, marking a decrease of 0.06.
• For EarningsYield, as of Mar 25, the value is 0.05. This value is below the healthy minimum of 5. It has decreased from 0.09 (Mar 24) to 0.05, marking a decrease of 0.04.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness